Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the CrossBoss First Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 246 participants.
Also called NCT02510547
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 246 participants
- Sponsor
- Registry
-
NCT02510547
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02510547. Randomized; single masking; primary purpose treatment. Start 2015-09 (registry gives no type); primary completion 2017-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
- Condition
- Arteriosclerosis
- Condition
- Coronary Artery Disease
- Condition
- Myocardial Ischemia
- Condition
- Coronary Disease
- Intervention (Procedure)
- CrossBoss Catheter
- Intervention (Procedure)
- Antegrade Wire Escalation Strategy
- Lead sponsor
- North Texas Veterans Healthcare System
- Collaborator
- Henry Ford Hospital
- Collaborator
- Massachusetts General Hospital
- Collaborator
- North Central Heart-Avera Sacred Heart Hospital
- Collaborator
- Saint Lukes Hospital Mid America Heart Institute
- Collaborator
- Missouri Heart Center
- Collaborator
- University of Washington
- Collaborator
- Deborah Heart and Lung Center
- Collaborator
- Minneapolis Heart Institute
- Collaborator
- Wellspan Heart and Vascular
- Collaborator
- United Heart and Vascular Clinic and United Hospital
Record details
- Record id
cardio:ct-nct02510547- Content hash
feb0678ca6eb35af0d77cb5b54bb687fc3b5c994c9fd3191abbdeb88360cac55